Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Fr | FDA Highlights Safety Concerns & Class I Recall for Getinge's Vasoview Hemopro Devices | 16 | Reuters | ||
11.11. | Getinge Announces Official Cybersecurity Clearance From the US Defense Health Agency for Servo Ventilators | 8 | Cision News | ||
07.11. | Alexandra Holland appointed as EVP Communications at Getinge | 3 | Cision News | ||
06.11. | GETINGE: Contributing to a legacy of life-saving technology | 4 | Cision News | ||
28.10. | GETINGE: Paragonix Technologies receives FDA 510(k) clearance for KidneyVault portable renal perfusion system | 7 | Cision News | ||
18.10. | Telefonkonferenz: Getinge meldet 10% Auftragswachstum, stagnierende organische Umsätze im dritten Quartal | 22 | Investing.com Deutsch | ||
18.10. | Earnings call: Getinge reports 10% order growth, flat organic sales in Q3 | 3 | Investing.com | ||
18.10. | Getinge AB (publ) reports Q3 results | 14 | Seeking Alpha | ||
GETINGE AB ADR Aktie jetzt für 0€ handeln | |||||
18.10. | Getinge Interim Report July-September 2024: Strong order intake but temporary delivery disruptions had a negative impact on earnings | 157 | PR Newswire | GOTHENBURG, Sweden, Oct. 18, 2024 /PRNewswire/ -- "The order intake increased by 10.0%, of which organic growth was 7.4%. All regions reported a positive performance," says Mattias Perjos, President... ► Artikel lesen | |
11.10. | Research and Markets: Europe Dental Infections Control Market Analysis and Forecast to 2033, Featuring Profiles of Key Players Steris, Getinge, BMS Dental, Coltene Group, ASA Dental and Tuttnauer - ResearchAndMarkets.com | 416 | Business Wire | The "Europe Dental Infections Control Market: Focus on Offering, End User, and Country Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering.
The European... ► Artikel lesen | |
09.10. | FleetView by Getinge elevates service with connected devices | 5 | Cision News | ||
04.10. | Getinge invites fund managers, analysts, and media to Q3 Report 2024 conference call | 14 | Cision News | ||
25.09. | Getinge's CE certificate for ECLS consumables reinstated | 19 | Cision News | ||
23.09. | Getinge partners with MEDITECH on Talis Clinical solutions to enhance anesthesia management | 4 | Cision News | ||
11.09. | Signet Healthcare Partners Completes Sale of Paragonix Technologies to Getinge | 84 | Business Wire | NEW YORK--(BUSINESS WIRE)--Signet Healthcare Partners ("Signet") is pleased to announce that one of its medical device portfolio companies, Paragonix Technologies ("Paragonix" or the "Company")... ► Artikel lesen | |
11.09. | Getinge completes $477M Paragonix acquisition | 3 | MassDevice | ||
11.09. | Getinge completes the acquisition of Paragonix Technologies | 2 | Cision News | ||
01.09. | Getinge makes a provision of MBRL 240 related to Brazilian investigation | 3 | Cision News | ||
26.08. | Getinge enters transplant market, buying organ transport specialist Paragonix for $477M | 3 | FierceBiotech | ||
26.08. | TransMedics stock rated a Buy amid Getinge acquisition | 5 | Investing.com |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FRESENIUS MEDICAL CARE | 41,440 | +1,57 % | DZ BANK stuft FMC FRESENIUS MEDICAL CARE AG & CO KGAA auf 'Halten' | FRANKFURT (dpa-AFX Analyser) - Die DZ Bank hat den fairen Wert für FMC von 37 auf 41 Euro angehoben und die Einstufung auf "Halten" belassen. Der Dialyseanbieter habe ein gelungenes Quartal hinter sich... ► Artikel lesen | |
ESSILORLUXOTTICA | 232,80 | -1,36 % | BERNSTEIN RESEARCH stuft EssilorLuxottica auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat das Kursziel für EssilorLuxottica von 194 auf 200 Euro angehoben, aber die Einstufung auf "Market-Perform" belassen. Analyst Luca... ► Artikel lesen | |
ALIGN TECHNOLOGY | 213,60 | +0,56 % | ALGN Stock to Gain From CE Mark Win for Invisalign Palatal Expander | ||
INMODE | 16,705 | -3,58 % | InMode Ltd.: InMode Reports Third Quarter 2024 Financial Results; Quarterly GAAP Revenue of $130.2 Million (which consists of $98.3 million of net sales in Q3 and $31.9 million of pre-orders from the ... | YOKNEAM, Israel, Oct. 30, 2024 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced... ► Artikel lesen | |
INVITAE | 0,110 | 0,00 % | Ex-Invitae Spinoff Relaunches as Citizen Health, Picks Up $14.5M in Seed Funding | ||
ELEVANCE HEALTH | 377,20 | -0,03 % | Aktie von Elevance Health erreicht 52-Wochen-Tief bei 397,93 US-Dollar | ||
TENET | 139,00 | -3,47 % | Commure rolls out AI scribe for Tenet Healthcare after yearlong customized build | ||
BONESUPPORT | 29,480 | +1,45 % | Bonesupport Holding AB: Bonesupport Holding AB (publ) - Publishes Q3 2024 Interim Report | BONESUPPORT HOLDING AB (publ), a leading company in orthobiologics for the management of bone injuries, today publishes the interim report for the third quarter 2024.
54% SALES GROWTH (CER), STRONG... ► Artikel lesen | |
ARJO | 2,824 | -1,05 % | Bruin Biometrics, LLC: Arjo and Bruin Biometrics conclude distribution agreement, Bruin Biometrics resumes direct sales and marketing of Provizio SEM Scanner | LOS ANGELES and LONDON, Nov. 6, 2024 /PRNewswire/ -- Today Bruin Biometrics and Arjo announce the immediate transition of direct sales and marketing of the Provizio® SEM Scanner to Bruin... ► Artikel lesen | |
AMN HEALTHCARE SERVICES | 23,200 | 0,00 % | AMN Healthcare stock hits 52-week low at $23.48 amid market shifts | ||
ALPHATEC | 9,200 | 0,00 % | Alphatec files to sell 1.13M shares of common stocks by selling shareholders | ||
FISHER & PAYKEL HEALTHCARE | 20,800 | 0,00 % | Dividendenbekanntmachungen (26.06.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ALLGEIER SE DE000A2GS633 - 0,5 EUR AMERICAN VANGUARD CORPORATION US0303711081 0,03 USD 0,028 EUR ARMADA HOFFLER PROPERTIES INC US04208T1088 0... ► Artikel lesen | |
CHECK-CAP | 0,705 | +3,68 % | Check-Cap Ltd - 6-K, Report of foreign issuer | ||
CROSS COUNTRY HEALTHCARE | 9,600 | 0,00 % | Cross Country Healthcare Announces Third Quarter 2024 Financial Results | BOCA RATON, Fla.--(BUSINESS WIRE)--Cross Country Healthcare, Inc. (the Company) (Nasdaq: CCRN) today announced financial results for its third quarter ended September 30, 2024.
SELECTED FINANCIAL... ► Artikel lesen | |
PENNANT GROUP | 28,800 | -1,37 % | Pennant Group, Inc.: Pennant Completes Acquisition of Signature Healthcare at Home's Washington and Idaho Assets | EAGLE, Idaho, Aug. 01, 2024 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, announced... ► Artikel lesen |